Glaukos commences trials for its third-generation keratoconus therapy Glaukos has commenced a Phase 2 clinical program for its third-generation iLink therapy designed to treat keratoconus.Read More rhiannon bowmanApril 11, 2022, 8:55 amApril 8, 2022
